-+ 0.00%
-+ 0.00%
-+ 0.00%

Corcept Therapeutics Director James N. Wilson Reports Disposal of $726,677.9383 in Common Shares

PUBT·11/17/2026 21:33:12
Diffusion vocale
Corcept Therapeutics Director James N. Wilson Reports Disposal of $726,677.9383 in Common Shares
  • Corcept Therapeutics director James N. Wilson sold 10,000 common shares on Nov. 13, 2026.
  • Reported transaction prices ranged from $71.8011 to $74.28 per share.
  • Following the sales, indirect holdings totaled 1,044,543 shares through a family trust, with another 400,000 shares held through two annuity trusts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-465604), on November 17, 2026, and is solely responsible for the information contained therein.